SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-045305
Filing Date
2023-04-14
Accepted
2023-04-14 07:30:52
Documents
4
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2310930d3_def14a.htm DEF 14A 552940
2 GRAPHIC tm2310930d3_def14aimg001.jpg GRAPHIC 121891
3 GRAPHIC tm2310930d3_def14aimg002.jpg GRAPHIC 102566
4 GRAPHIC tm2310930d3_def14aimg003.jpg GRAPHIC 7739
  Complete submission text file 0001104659-23-045305.txt   874201
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39231 | Film No.: 23819727
SIC: 2836 Biological Products, (No Diagnostic Substances)